Academic Journal

Comparing morphology, flow cytometry and molecular genetics in the assessment of minimal residual disease in children with B-acute lymphoblastic leukaemia (B-ALL)

التفاصيل البيبلوغرافية
العنوان: Comparing morphology, flow cytometry and molecular genetics in the assessment of minimal residual disease in children with B-acute lymphoblastic leukaemia (B-ALL)
المؤلفون: Candice L. Hendricks, Suvarna Buldeo, Dashini Pillay, Ashendran Naidoo, Rajendra Thejpal, Nadine Rapiti, Beverley Neethling, Yasmin Goga, Hamida van Staaden
المصدر: South African Journal of Oncology, Vol 3, Iss 0, Pp e1-e8 (2019)
بيانات النشر: AOSIS, 2019.
سنة النشر: 2019
المجموعة: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية: minimal residual disease, b-acute lymphoblastic leukaemia, paediatric, flow cytometry, molecular genetics, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
الوصف: ackground:Minimal residual disease (MRD) detection has been shown to be the best prognostic factor in B-acute lymphoblastic leukaemia (B-ALL). Multicolour flow cytometry (FCM) and specific molecular aberrations (MOL) are the classic techniques used to assess MRD. The former is faster and less costly. Aim: This study compares morphology and FCM to MOL in detecting MRD. Setting: The study was conducted at Inkosi Albert Luthuli Central Hospital (IALCH). Methods: A retrospective review of children with B-ALL managed at IALCH from January 2013 to January 2018 was conducted. Multicolour flow cytometry was performed using Euroflow® panels. Molecular aberrations looked at common cytogenetic markers. Presentation and post-induction morphology (May–Grunwald Giemsa stain), FCM and MOL data for MRD were analysed. Results: Eleven patients were excluded (6-demised, 5-incomplete records), leaving 64 to be analysed (54% female, median age 5 years). Five post-induction aspirates were unsuitable but the rest (92%) were in morphological remission. At diagnosis and post-induction, 62 (95%) and 61 (94%) children, respectively, had FCM performed. A positive MOL result was found in 39 (60%) patients. MOL turn-around times (TATs) averaged 14 days compared with those of FCM’s average of 3 days. MRD was found in 9 patients (FCM) and 7 patients (MOL). Of these patients, 4 had a good correlation between the two and 2 patients with negative FCM had positive MOL MRD post-induction. Conclusion: Morphology is insensitive in MRD assessment. FCM correlated well with molecular MRD and has the shortest turn-around time. FCM has major benefit in the 40% of patients with negative MOL. It can also be safely used to guide treatment escalation in those patients awaiting molecular results.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2518-8704
2523-0646
Relation: https://sajo.org.za/index.php/sajo/article/view/76; https://doaj.org/toc/2518-8704; https://doaj.org/toc/2523-0646
DOI: 10.4102/sajo.v3i0.76
URL الوصول: https://doaj.org/article/ceb22fc6b85d4fe3901249b488b4a226
رقم الانضمام: edsdoj.b22fc6b85d4fe3901249b488b4a226
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:25188704
25230646
DOI:10.4102/sajo.v3i0.76